Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study - The Lancet Microbe

Por um escritor misterioso

Last updated 09 novembro 2024

Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study - The Lancet Microbe

CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19—Definition and Evaluation

It was difficult to offer same day results”: evaluation of community-based point-of-care testing for sexually transmitted infections among youth using the GeneXpert platform in Zimbabwe, BMC Health Services Research

Validation of rapid, molecular testing for COVID-19 and integration with TB diagnostics - Peru

The ongoing challenge of latent tuberculosis Philosophical Transactions of the Royal Society B: Biological Sciences

Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19

Rifampicin mono-resistant tuberculosis is not the same as multidrug-resistant tuberculosis: a descriptive study from Khayelitsha, South Africa

The Lancet Commission on diagnostics: transforming access to diagnostics - The Lancet

Full article: Saliva as a sample type for SARS-CoV-2 detection: implementation successes and opportunities around the globe

Six decades of lateral flow immunoassay: from determining metabolic markers to diagnosing COVID-19

Accuracy of Commercial Molecular Diagnostics for the Detection of Pulmonary Tuberculosis in China: A Systematic Review

Microscopic observation drug susceptibility assay for the diagnosis of TB and MDR-TB in HIV-infected patients: a systematic review and meta-analysis

Year in review - Infectious diseases and immunity in global health program - IDIGH - Annual Report 2023 - Research Institute of the McGill University Health Centre - RI-MUHC

Recomendado para você